Discontinuation report APO-SUCRALFATE - TAB 1G

Last updated on 2018-09-15 History
Report ID 61033
Drug Identification Number 02125250
Brand name APO-SUCRALFATE - TAB 1G
Common or Proper name SUCRALFATE
Company Name APOTEX INC
Market Status MARKETED
Active Ingredient(s) SUCRALFATE
Strength(s) 1G
Dosage form(s) TABLET
Route of administration ORAL
Packaging size 500 BTL
ATC code A02BX
ATC description DRUGS FOR PEPTIC ULCER AND GASTROESOPHAGEAL REFLUX DISEASE (GERD)
Reason for discontinuation Raw material availability
Anticipated discontinuation date
Actual discontinuation date 2018-09-14
Remaining supply date 2018-09-14
Discontinuation status Discontinued
Discontinuation decision reversal No
Information on remaining supply
Company comments
Health Canada comments
Contact Address 150 SIGNET DRIVE
TORONTO, ONTARIO
CANADA M9L 1T9
Company contact information Apotex Customer Service - 1-877-427-6839

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v3 2018-09-15 English Compare
v2 2018-09-10 French Compare
v1 2018-09-10 English Compare